ישראל - עברית - Ministry of Health

novapharma ltd - oxaliplatin 5 mg/ml - concentrate for solution for infusion - oxaliplatin - in combination with 5- fluorouracil and folinic acid (fa) oxaliplatin is indicated for: - adjuvant treatment of stage iii ( duke's c) colon cancer after complete resection of primary tumour - the treatment of metastatic colorectal cancer.

ישראל - עברית - Ministry of Health

merck serono ltd - cetuximab - תמיסה לאינפוזיה - cetuximab 5 mg/ml - cetuximab - cetuximab - erbitux® is indicated for the treatment of patients with epidermal growth factor receptor (egfr) - expressing, kras wild-type metastatic colorectal cancer• in combination with irinotecan-based chemotherapy• in first-line in combination with folfox• as a single agent in patients who have failed oxaliplatin- and irinotecan-based therapy and who are intolerant to irinotecanerbitux is indicated for the treatment of patients with squamous cell cancer of the head and neck (scchn)• in combination with radiation therapy for locally advanced disease• in combination with platinum-based chemotherapy for recurrent and/or metastatic disease• as a single agent after failure of platinum-based chemotherapy for recurrent and/or metastatic disease

ישראל - עברית - Ministry of Health

bayer israel ltd - regorafenib - טבליות מצופות פילם - regorafenib 40 mg - regorafenib - regorafenib - stivarga is indicated for the treatment of patients with metastatic colorectal cancer (crc) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-vegf therapy, and if kras wild-type, an anti-egfr therapy.for the treatment of patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumors (gist) who have been previously treated with imatinib mesylate and sunitinib malate

ישראל - עברית - Ministry of Health

amgen europe b.v. - panitumumab - תרכיז להכנת תמיסה לאינפוזיה - panitumumab 20 mg / 1 ml - panitumumab - in combination with chemotherapy for the treatment of unresectable, advanced or recurrent colorectal cancer (mcrc) with wild-type kras.monotherapy for the treatment of patients with metastatic colorectal carcinoma with wild-type kras after failure of fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimens.

ישראל - עברית - Ministry of Health

sanofi - aventis israel ltd - aflibercept 25 mg/ml - concentrate for solution for infusion - zaltrap, in combination with 5-fluorouracil, leucovorin, irinotecan (folfiri), is indicated for adults with metastatic colorectal cancer (mcrc) that is resistant to or has progressed following an oxaliplatin-containing regimen.

ישראל - עברית - Ministry of Health

inovamed ltd - capecitabine - טבליות מצופות פילם - capecitabine 500 mg - capecitabine

ישראל - עברית - Ministry of Health

inovamed ltd - capecitabine - טבליות מצופות פילם - capecitabine 500 mg - capecitabine

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - capecitabine - טבליות מצופות פילם - capecitabine 150 mg - capecitabine

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - capecitabine - טבליות מצופות פילם - capecitabine 500 mg - capecitabine

ישראל - עברית - Ministry of Health

taro international ltd, israel - capecitabine - טבליות מצופות פילם - capecitabine 500 mg - capecitabine